These results suggested that DPP8/9 is a realistic potential therapeutic target for the management of multiple myeloma; however, it was reported that the cell death of THP-1 monocytes induced by 1G244 was not dependent on DPP8/938. The gene discussed is DPP8; the disease is plasma cell myeloma.